Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Irini Katodritou"'
Autor:
Konstantinos Vahtsevanos, Evgenia Verrou, C. Andreadis, Athanassios Kyrgidis, Irini Katodritou, Kyriaki Kitikidou
Publikováno v:
Journal of Clinical Oncology. 28:e145-e147
Autor:
Maria Roussou, Efstathios Kastritis, Meletios A. Dimopoulos, Anastasia Pouli, N. Anagnostopoulos, Sossana Delimpassi, Argiris Symeonidis, Dimitrios Christoulas, Theofanis Economopoulos, Dimitra Gika, Evangelos Terpos, Evridiki Michali, Athanasios Zomas, Konstantinos Zervas, Irini Katodritou
Publikováno v:
Blood. 112:655-655
Since the 1960s the survival of patients with MM had remained rather stable, until the introduction of high-dose melphalan with autologous stem cell transplant (ASCT) in the early 90s which improved the survival of younger patients. In 1999, thalidom
Autor:
Anastasia Pouli, Dimitra Mihou, Panagiotis Zikos, Nikolaos Anagnostopoulos, Chrisanthi H. Mitsouli, Athanasios Anagnostopoulos, Marie-Christine Kyrtsonis, Evangelos Terpos, Irini Katodritou, Meletios A. Dimopoulos, Konstantinos Zervas, Souzana Delimbasi
Publikováno v:
Blood. 108:794-794
Introduction: VAD-doxil and VAD-doxil plus thalidomide have already been separately evaluated, as initial cytoreductive treatment in multiple myeloma, in two previous clinical trials of our study group. Both regimens proved effective yielding overall
Autor:
Meletios A. Dimopoulos, Konstantinos Tsionos, Irini Katodritou, Vangelis Eleftherakis-Papaiakovou, Efstathios Kastritis, Konstantinos Zervas, Evangelos Terpos, Athanasios Anagnostopoulos
Publikováno v:
Blood. 108:5006-5006
Angiogenesis is essential step of disease progression in several hematologic malignancies including multiple myeloma (MM). Bone marrow (BM) angiogenesis, assessed by microvessel density (MVD), is increased in 30% of patients with WM and showed only w